Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) - Investor Dashboard


➔ Liberty Health Sciences
CSE Ticker: LHS
OTCQX Ticker: LHSIF
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada/U.S.
Employees: 75 as of 6/27/18
Established: 2017
Interim CEO: Victor E. Mancebo

Liberty Health Sciences – Management Team & Board


Victor E. Mancebo – Interim CEO

  • Victor is a resident in the State of Florida and has in-depth knowledge of the Company’s day to day operations. Victor’s appointment ensures that there will be no need for a ramping up period to become familiar with the Company’s operations. Victor will serve as the Company’s interim Chief Executive Officer and will be appointed to fill the vacancy on the Board until a replacement is sourced for the role.

Sheri Cholodofsky – CFO

  • As CFO, Sheri is responsible for leading the company’s finance functions. Her past experience includes working at Miami Air International, human resources company Creative Staffing, and global accounting firm BDO. She is a certified public accountant with a strong background in finance, accounting, human resources, operations management, and M&A activity. Sheri earned her Bachelor of Science degree in accounting from the University of Florida and her Master of Accounting degree from Florida International University.

Cole Cacciavillani, Chief Agronomist and Cofounder of Aphria

  • 35+ years in the agriculture business
  • Greenhouse industry pioneer
  • First-hand knowledge of Aphria’s greenhouses

Stephanie Kubacki, Vice President of Marketing

  • 18 years in the alcohol beverage industry
  • Former Director of Strategic Partnerships at InsightAction, Inc.

Board of Directors


Aaron Serruya – CEO, YogenFrüz
  • Leader in franchises, co-founder and CEO of YogenFrüz
  • Winner of numerous awards for business excellence
  • Will lead the dispensary expansion initiative in Florida and other states where investments are made

Significant Insider Ownership


Aaron Serruya, Director:
7.33 million shares and 1.1 million options

John Cervini, Director:
481K shares and 1.2 million options

Vic Neufeld, Director:
280K shares and 1.85 million options


Visit Liberty Health Sciences Inc.,
at www.libertyhealthsciences.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Liberty Health Sciences, Inc. is a client of NCV Media, LLC. Read our full disclaimer.